UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...

American health officials have recommended temporarily halting the use of Ixchiq (chikungunya virus vaccine, live) in people ...

US biotech PTC Therapeutics released mixed new data on its Phase II trial of PCT187 (votoplam) in Huntington’s disease. UK ...

The US Food and Drug Administration (FDA) has approved Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets) ...

US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

US precision oncology company Boundless Bio (Nasdaq: BOLD) has announced financial results and business highlights for the ...

Switzerland-based HAYA Therapeutics, a biotech developing precision RNA-guided regulatory genome targeting therapeutics that ...

A Feature on M&A, VC investment, licensing and partnerships in the radiopharmaceuticals arena.

Genmab (Nasdaq: GMAB) posted a 19% rise in revenue to $715 million for the first quarter of 2025, driven by higher royalties ...

The UK government has announced a trade agreement with the USA. The UK-US Economic Prosperity Deal was agreed on Thursday May ...